BJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

British Journal of Radiology (2005) 78, 34-38
© 2005 British Institute of Radiology
doi: 10.1259/bjr/79694026

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pettersson, H B L
Right arrow Articles by Scott, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pettersson, H B L
Right arrow Articles by Scott, M

Full Paper

Radiation risk and cost-benefit analysis of a paediatric radiology procedure: results from a national study

H B L Pettersson, PhD1, K Fälth-Magnusson, MD, PhD2, J Persliden, PhD1,3 and M Scott, PhD4

1 Department of Radiation Physics, IMV and 2 Department of Paediatrics, IMK, Faculty of Health Science, University of Linköping, S-581 85 Linköping, Sweden, 3 Department of Medical Physics, Örebro University Hospital, S-701 85 Örebro, Sweden and 4 Department of Statistics, University of Glasgow, Glasgow G12 8QW, UK

A national study was performed to investigate radiation doses and associated risks to patients during X-ray fluoroscopy-guided small intestinal biopsies in the investigation of coeliac disease. Thermoluminescent dosemeters (TLD) and questionnaires were sent to 42 of the 43 paediatric departments in Sweden performing these biopsies. During the study period (2 x 3 weeks) 257 biopsies were recorded, representing about 10% of annually performed paediatric investigations. The results show that the absorbed dose during biopsy ranged from 0.04 mGy to 23.8 mGy (mean 1.87 mGy). The fluoroscopy time ranged from 2 s to 663 s (mean 60 s). The collective dose from the procedure amounts to 4.7 manSv year–1. Thus, the annual excess cancer mortality, including severe hereditary effects, can be estimated at 0.6–0.7 cases per year. However, significant dose saving can be obtained by proper choice of sedation and biopsy equipment.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
BJR DMFR IMAGING  ALL BIR JOURNALS 
Copyright © 2005 by the British Institute of Radiology.